Elizabeth A. Garofalo - Sep 2, 2025 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role: Director
Signature: /s/ Jennifer J. Rhodes, Attorney-in-Fact
Stock symbol: ACAD
Transactions as of: Sep 2, 2025
Transactions value $: -$41,560
Form type: 4
Date filed: 9/3/2025, 06:00 PM
Previous filing: Jun 12, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GAROFALO ELIZABETH A.	Director	C/O ACADIA PHARMACEUTICALS INC., 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO	/s/ Jennifer J. Rhodes, Attorney-in-Fact	2025-09-03	0001826361

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACAD	Common Stock	Sale	-$41.6K	-1.6K	-5.93%	$25.98	25.4K	Sep 2, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.97 to $25.991, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.97 to $25.991, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.